The START Center for Cancer Research

Hematology APP/NP

The START Center for Cancer Research  •  Grand Rapids, MI (Onsite)  •  12 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

The START Center for Cancer Research (“START”) is the world’s largest early phase site network, fully dedicated to oncology clinical research. Throughout our history, START has provided hope to cancer patients in global community practices by offering  "Hope Through Access” to cutting edge trials throughout the United States and Europe.  

We are seeking a Hematology Advanced Practice Provider / Nurse Practitioner

This role supports protocol-compliant patient care and clinical trial execution for Phase I and other early-phase oncology studies. Functioning as a sub-investigator under the supervision of the Principal Investigator (PI), the APP/NP extends clinical capacity, supports screening and study visits, and enhances care coordination while preserving core investigator responsibilities specific to early-phase research.

Work Schedule:  Monday-Friday, 8:00am-5:00pm

Location: 800 Foremost Dr SE, Grand Rapids, Michigan,49546

Essential Responsibilities:

  • Serve as a sub-investigator on assigned early-phase clinical trials following completion of required training and delegation documentation.
  • Conduct protocol-required physical examinations and study visits for patients in screening, on treatment, and in follow-up as delegated by the Principal Investigator.
  • Prepare comprehensive medical histories and clinical summaries in advance of new patient consults to support efficient PI evaluation.
  • Assist with screening activities prior to new patient visits, including preliminary chart review and protocol feasibility assessment.
  • Support post-consent screening by assisting with protocol-specific screening questions and required clarifications.
  • Assist with the identification, documentation, and follow-up of adverse events (AEs) and serious adverse events (SAEs) in collaboration with the Principal Investigator and research team. Attend sponsor or safety calls designated as low priority or routine, as delegated by the Principal Investigator.
  • Act as the first point of clinical contact for the research care team for day-to-day patient management questions and escalate issues to the Principal Investigator as appropriate.
  • Coordinate with nursing, pharmacy, clinical research coordinators, and data management to ensure safe, efficient, and protocol-adherent care delivery.

Required Education and Experience:

  • Advanced practice degree (Nurse Practitioner or Physician Assistant) with current licensure in the applicable state(s).
  • Minimum of 5 years of experience in oncology clinical care or oncology clinical research.

Preferred Education and Experience:

  • Master’s degree or Doctoral degree in advanced practice nursing or physician assistant studies.
  • National certification as a Nurse Practitioner or Physician Assistant. Eligibility and willingness to serve as a sub-investigator on oncology clinical trials.
  • Prior experience in early-phase (Phase I) oncology clinical research.

More About START

START clinical trial sites have conducted more than 1,000 early-phase clinical trials, including dozens of therapies that were approved by the FDA or EMA. START represents the world’s largest roster of early-phase principal investigators across its Network of clinical trial sites. Committed to accelerating passage from trials to treatments, START delivers hope to patients, families, and physicians around the world via our mission of “Hope Through Access”.

Learn more at  STARTresearch.com  

Ready to be part of a team changing the future of cancer treatment?

Join us in our mission to conquer cancer, one clinical trial at a time. Your expertise and dedication can help us bring hope and healing to patients worldwide. Please submit your application online. 

We are an equal opportunity employer that welcomes and encourages diversity in the workplace. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law. 

The START Center for Cancer Research

About The START Center for Cancer Research

Deeply rooted in community oncology centers globally, the START Center for Cancer Research ("START") provides patients with access to specialized Phase 1 clinical trials for novel anti-cancer agents. With research sites in the United States and in Spain, Portugal, and Ireland, START’s clinical trial sites have conducted more than 1,500 early phase clinical trials, including for 45 therapies that have gained FDA/EMA approval. Founded in Texas in 2007, START today boasts 30+ Principal Investigators (PIs) across its worldwide clinical trial sites. With over 100,000+ square feet of world-class research facilities, START offers patients comprehensive treatment plans that include multi-specialty services, genetic profiling of tumors, targeted therapies, state-of-the-art treatment technology, and advanced access to clinical research options. START is committed to accelerating passage from trials to treatments, and to delivering hope to patients, families, and physicians around the world.

Industry
Biotech & Life Sciences
Company Size
201-500 employees
Headquarters
San Antonio, Texas
Year Founded
Unknown
Social Media